Illumina Webinar: Adopt NGS for Tumor Profiling

Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while simultaneously helping to preserve precious samples. In this webinar, you will learn more about the advantages that NGS offers over traditional methods, and be introduced to the newest, cost effective solution for hematological and solid tumor profiling.

Discover the efficiencies of comprehensive tumor profiling with NGS:

• Reduce precious sample requirements.
• Minimize workflow protocols and save on turn-around-time.
• Simplify reporting with all relevant genes in one.
• Reduce costs by assessing multiple genes at once.

Explore new sample to data oncology solutions:

• Leverage an easy-to-use portfolio of targeted cancer gene panels.
• See the power and simplicity of the new MiniSeq™ Benchtop Sequencer.
• Experience automated, simplified analysis tools.

Date:	Wednesday, February 24
Time:	9:00 AM (PT)
Speakers:	Maude Champagne Commercial Development Manager Oncology, Illumina Claire Ray Associate Product Manager Oncology, Illumina